ORAGENICS INC - Common Stock (OGEN)

CUSIP: 684023609

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
4,168,222
Total 13F shares
122,534
Share change
+87,886
Total reported value
$160,519
Price per share
$1.31
Number of holders
15
Value change
+$106,064
Number of buys
5
Number of sells
9

Security key

684023609

Report period

Q3 2025

Institutions

15

Top holders

10

Top shareholders of OGEN - ORAGENICS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Five Narrow Lane LP
13D/G
10%
82,210
$0 02 Jul 2025
CLEAR STREET LLC
13F
Company
1.7%
70,619
$269,765 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.37%
15,546
$59,386 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.29%
11,912
$45,504 30 Jun 2025
13F
FNY Investment Advisers, LLC
13F
Company
0.06%
2,500
$9,000 30 Jun 2025
13F
UBS Group AG
13F
Company
0.05%
1,892
$7,227 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
0.02%
701
$2,678 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
681
$2,602 30 Jun 2025
13F
Lionsbridge Wealth Management LLC
13F
Company
0.02%
667
$2,548 30 Jun 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
665
$2,540 30 Jun 2025
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
34
$130 30 Jun 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
34
$130 30 Jun 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
10
$38 30 Jun 2025
13F
Activest Wealth Management
13F
Company
0%
2
$8 30 Jun 2025
13F
EVERMAY WEALTH MANAGEMENT LLC
13F
Company
0%
1
$4 30 Jun 2025
13F
Farther Finance Advisors, LLC
13F
Company
0%
1
$4 30 Jun 2025
13F
Strategic Wealth Partners, Ltd.
13F
Company
0%
1
$4 30 Jun 2025
13F
CHESAPEAKE ASSET MANAGEMENT LLC
13F
Company
0%
1
$3 30 Jun 2025
13F
Odyssey Health, Inc.
3/4/5
10%+ Owner
class O/S missing
249,623
17 Jun 2025
Bruce A. Cassidy Sr.
3/4/5
Director
mixed-class rows
399,728
mixed-class rows
$1,265,705 19 Sep 2024
Michael O Sullivan
3/4/5
Chief Financial Officer
class O/S missing
200,000
29 Jul 2022
J. Michael Redmond
3/4/5
President
class O/S missing
100,000
19 Sep 2024
Kimberly M. Murphy
3/4/5
Director
class O/S missing
27,083
19 Sep 2024

Institutional Holders of ORAGENICS INC - Common Stock (OGEN) as of Q3 2025

As of 30 Sep 2025, ORAGENICS INC - Common Stock (OGEN) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,534 shares. The largest 10 holders included DRW Securities, LLC, SABBY MANAGEMENT, LLC, BlackRock, Inc., Allworth Financial LP, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, BANK OF AMERICA CORP /DE/, HARBOUR INVESTMENTS, INC., and WELLS FARGO & COMPANY/MN. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
17
Q3 2025 holders
15
Holder diff
-2
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .